Sequana Medical NV (STU:2SE) EV-to-EBIT : -1.58 (As of May. 26, 2024)

View and export this data going back to 2019. Start your Free Trial

What is Sequana Medical NV EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Sequana Medical NV's Enterprise Value is €48.16 Mil. Sequana Medical NV's EBIT for the trailing twelve months (TTM) ended in Jun. 2023 was €-30.42 Mil. Therefore, Sequana Medical NV's EV-to-EBIT for today is -1.58.

The historical rank and industry rank for Sequana Medical NV's EV-to-EBIT or its related term are showing as below:

STU:2SE' s EV-to-EBIT Range Over the Past 10 Years
Min: -9.93 Med: -5.21 Max: -1.03
Current: -1.58

During the past 9 years, the highest EV-to-EBIT of Sequana Medical NV was -1.03. The lowest was -9.93. And the median was -5.21.

STU:2SE's EV-to-EBIT is ranked worse than
100% of 458 companies
in the Medical Devices & Instruments industry
Industry Median: 20.17 vs STU:2SE: -1.58

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Sequana Medical NV's Enterprise Value for the quarter that ended in Jun. 2023 was €89.33 Mil. Sequana Medical NV's EBIT for the trailing twelve months (TTM) ended in Jun. 2023 was €-30.42 Mil. Sequana Medical NV's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Jun. 2023 was -34.06%.

Sequana Medical NV EV-to-EBIT Historical Data

The historical data trend for Sequana Medical NV's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sequana Medical NV EV-to-EBIT Chart

Sequana Medical NV Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

EV-to-EBIT

Get a 7-Day Free Trial

-5.44

-10.24

-6.13

-4.79

Sequana Medical NV Semi-Annual Data
	Dec15	Dec16	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
EV-to-EBIT	Get a 7-Day Free Trial									-	-6.13	-	-4.79	-

Competitive Comparison of Sequana Medical NV's EV-to-EBIT

For the Medical Devices subindustry, Sequana Medical NV's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sequana Medical NV's EV-to-EBIT Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Sequana Medical NV's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Sequana Medical NV's EV-to-EBIT falls into.

Sequana Medical NV EV-to-EBIT Calculation

Sequana Medical NV's EV-to-EBIT for today is calculated as:

EV-to-EBIT	=	Enterprise Value (Today)	/	EBIT (TTM)
	=	48.155	/	-30.423
	=	-1.58

Sequana Medical NV's current Enterprise Value is €48.16 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Sequana Medical NV's EBIT for the trailing twelve months (TTM) ended in Jun. 2023 was €-30.42 Mil.

Sequana Medical NV (STU:2SE) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Sequana Medical NV's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Jun. 2023 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Jun. 2023 )	=	EBIT	/	Enterprise Value (Q: Jun. 2023 )
	=	-30.423	/	89.325855
	=	-34.06 %

Sequana Medical NV's Enterprise Value for the quarter that ended in Jun. 2023 was €89.33 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Sequana Medical NV's EBIT for the trailing twelve months (TTM) ended in Jun. 2023 was €-30.42 Mil.

Sequana Medical NV EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Sequana Medical NV's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Sequana Medical NV (STU:2SE) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sequana Medical NV (STU:2SE) » Definitions » EV-to-EBIT

Comparable Companies

Traded in Other Exchanges

2SE:Germany SEQUA:Belgium

Address

Kortrijksesteenweg 1112 ,bus 102, Sint-Denijs-Westrem, Ghent, BEL, 9051

Website

https://www.sequanamedical.com

Sequana Medical NV is a commercial-stage medical device company focused on the development of treatment solutions for the management of fluid overload in liver disease, malignant ascites, and heart failure. The company's products include an alfa pump, which provides a treatment solution for the long-term management of liver refractory ascites and malignant ascites with safety, efficacy, and quality of life benefits demonstrated in multiple clinical studies and over 750 implants. The company's geographical segments include Switzerland, Germany, the United Kingdom, and the Rest of the world, out of which Germany accounts for the majority of the revenue.

Sequana Medical NV (STU:2SE) Headlines

No Headlines